CDH Investments-backed Chinese Biotechnology Firm Mabpharm Files For Hong Kong IPO

Login to View

Mabpharm Limited, a Taizhou, Jiangsu Province-based biotechnology company, has filed for an initial public offering in Hong Kong, becoming the latest Chinese biotech firm rushing for a Hong Kong IPO. 

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets
Sophy Yang maintains our exclusive DealShot service. Culled from thousands of online data points, our China Money AI gathers data, and then Sophy fills in the "last mile" to make sure the data is accurate for our clients who rely on this critical deal flow data.